MiniMed delivered strong Q1 2027 results with net sales of $843 million, aided by U.S. acceleration and robust international growth. The company raised fiscal year organic revenue guidance and highlighted key FDA submissions and product launches.
MiniMed delivered strong Q1 2027 results with net sales of $843 million, aided by U.S. acceleration and robust international growth. The company raised fiscal year organic revenue guidance and highlighted key FDA submissions and product launches.